Amsbio: Room Temperature Cell Preservation Technology

Hits:65   Date: 9/23/2026

Amsbio announce a new partnership with Atelerix to introduce its patented hydrogel technology for the room-temperature storage and transportation of living cells, tissues, organoids and viruses.
 
Preserving cell functionality during storage and transportation is challenging for cell-based therapies as cryopreservation methods can compromise cell viability and functionality. The novel hypothermic hydrogel technology, available from Amsbio, offers a revolutionary alternative, addressing many of the issues associated with cryopreservation.

How hypothermic hydrogel preserves cells at room temperature

 
This seaweed-derived hydrogel forms a protective shield around cells. It keeps them stable and healthy outside of ultra-cold freezers letting you store and ship delicate biological samples at room temperature without freezing. Using this exceptional proprietary hydrogel – over 90% of cells remain viable and maintain key sample characteristics such as viability, phenotype, morphology and function in supplier-tested workflows.

Illustration of human cells

 
Eliminating the need for expensive liquid nitrogen tanks, ultra-low freezers or costly dry ice shipping not only has huge economic benefits but it also cuts down on energy use and carbon emissions.
 
Cells preserved using this hypothermic hydrogel technology stay ready to use at room temperature for days or up to two weeks. No longer do you have to rush processing right after a sample is thawed.
 
Hydrogel availability in dedicated formulations and scalable formats allows optimised selection according to sample type, volume, plate format and downstream application. For further information please visit https://www.amsbio.com/suppliers/atelerix/ or contact Amsbio on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.
 
Amsbio, part of the Europa Biosite group, is a leading life sciences company supporting drug discovery, translational research, and cell and gene therapy across Europe, North America, and wider international markets. With in depth expertise in advanced cell culture, 3D cell models, and cryopreservation, Amsbio is well placed to help researchers progress from early discovery through to clinical and GMP-ready applications. The company’s portfolio of innovative products and services supports multiple stages of the research pipeline, spanning target discovery, assay development, and disease modelling, through to stem cell and organoid-based research. Key solutions include the integrated stem cell platform combining StemFit™ media, iMatrix™ recombinant laminins, and CELLBANKER™ cryopreservation technology, alongside extracellular matrix technologies, biospecimens, glycobiology.
 
tools, kits and assays, and a wide range of custom services including viral delivery. Drawing on extensive GMP expertise and a comprehensive human and animal biorepository, Amsbio is internationally recognized for delivering high-quality, application-ready products and services. Amsbio has a consistent record of close scientific collaboration with partners in academic, biotech, and pharmaceutical markets to translate innovation from bench to bedside.
 
---------------------

Worldwide HQ
AMS Biotechnology Europe Ltd (Amsbio)
2-3, Munro House
Trafalgar Way
Bar Hill
Cambridge, CB23 8SQ
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com
Web www.amsbio.com
 
North American HQ
Amsbio LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com
Web www.amsbio.com